![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.citizentribune.com/news/business/elanco-closes-acquisition-of-kindred-biosciences/article_8d955d9f-e0fc-57ee-9ff0-eab5a538d149.html
https://www.biospace.com/article/releases/elanco-announces-agreement-to-acquire-kindred-biosciences/?s=79
https://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-first-quarter-2021-financial-results-301281866.html
https://www.prnewswire.com/news-releases/kindred-biosciences-announces-acceptance-of-parvovirus-antibody-prophylaxis-study-data-and-approval-of-efficacy-indication-301278746.html
https://www.prnewswire.com/news-releases/kindred-biosciences-to-announce-fourth-quarter-and-full-year-2020-financial-results-301241668.html
https://www.prnewswire.com/news-releases/kindred-biosciences-to-present-at-the-bofa-securities-animal-health-virtual-summit-301229317.html
https://www.prnewswire.com/news-releases/kindred-biosciences-announces-positive-results-from-pilot-field-effectiveness-study-for-anti-tnf-antibody-for-canine-inflammatory-bowel-disease-301196541.html
https://www.prnewswire.com/news-releases/kindred-biosciences-announces-agreement-granting-elanco-exclusive-global-rights-for-its-parvovirus-monoclonal-antibody-301191004.html